{"created":"2023-06-20T15:59:54.682630+00:00","id":18055,"links":{},"metadata":{"_buckets":{"deposit":"6f08f75b-26de-4396-85d9-48d442bd252f"},"_deposit":{"created_by":41,"id":"18055","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"18055"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00018055","sets":["340","340:341","340:341:682"]},"author_link":["68697","68695","68698","68696"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2022-04-22","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"3","bibliographicPageStart":"1","bibliographicVolumeNumber":"26","bibliographic_titles":[{"bibliographic_title":"高知赤十字病院医学雑誌"},{"bibliographic_title":"Medical Journal of Japanese Red Cross Kochi Hospital","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"高リン血症治療薬であるクエン酸第二鉄水和物（FCH）は下痢などの消化器系の副作用が比較\n的多く，また，副次効果として鉄補充効果があることが知られており，1日3回投与では，消化器症状\nの副作用や血清フェリチン（Ft）値の上昇を来し，中止を余儀なくされる症例がある．\n今回，慢性維持血液透析患者で，リン吸着目的で 1 日 3 回投与にて，副作用で中止を余儀なくされた\n9症例での，1日1錠（250mg）投与の経験について報告する．\nFt 値上昇群 6 例では，15 〜 30ヶ月間 Ft 値＞ 300ng/ml となった症例はなかった．消化器症状にて中\n止した症例でも，8〜37ヶ月間投与が可能であった．また，1錠投与により，鉄補充効果が得られた．","subitem_description_type":"Abstract"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"高知赤十字病院"}]},"item_10001_rights_15":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"高知赤十字病院"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0919-7427","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"田村, 雅人"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"角陸, 文哉"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"細川, 忠宣"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"奈路田, 拓史"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-04-22"}],"displaytype":"simple","filename":"維持血液透析（HD）患者におけるクエン酸第二鉄水和物（FCH）.pdf","filesize":[{"value":"515.5 kB"}],"format":"application/pdf","licensetype":"license_9","mimetype":"application/pdf","url":{"label":"高知赤十字病院医学雑誌Vol.26-23","url":"https://redcross.repo.nii.ac.jp/record/18055/files/維持血液透析（HD）患者におけるクエン酸第二鉄水和物（FCH）.pdf"},"version_id":"e79ac406-e3a2-4503-850a-4feefa961d41"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"維持透析","subitem_subject_scheme":"Other"},{"subitem_subject":"クエン酸第二鉄水和物","subitem_subject_scheme":"Other"},{"subitem_subject":"1日1錠投与","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"維持血液透析（HD）患者におけるクエン酸第二鉄水和物（FCH） 投与中止症例での FCH 1日1錠投与の経験","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"維持血液透析（HD）患者におけるクエン酸第二鉄水和物（FCH） 投与中止症例での FCH 1日1錠投与の経験"}]},"item_type_id":"10001","owner":"41","path":["340","341","682"],"pubdate":{"attribute_name":"公開日","attribute_value":"2022-04-22"},"publish_date":"2022-04-22","publish_status":"0","recid":"18055","relation_version_is_last":true,"title":["維持血液透析（HD）患者におけるクエン酸第二鉄水和物（FCH） 投与中止症例での FCH 1日1錠投与の経験"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2023-06-20T17:47:53.882174+00:00"}